# Replimune Group, Inc.: Form 8-K, filed Aug 3, 2023

- Company: [Replimune Group, Inc.](/companies/repl.md) (CIK 1737953)
- Form: 8-K
- Filed: 2023-08-03
- Accepted by EDGAR: Aug 3, 2023, 09:04 ET
- Period: 2023-08-03
- Accession: 0001104659-23-087083
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1737953/000110465923087083/tm2317748d1_8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1737953/000110465923087083/

## Items reported

- Item 1.01: Entry into a material agreement
- Item 1.02: Termination of a material agreement
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1737953/000110465923087083/tm2317748d1_8k.htm

Filed Aug 3, 2023.
Source: SEC EDGAR, the filing index for accession 0001104659-23-087083. Last ingested by Listed: Nov 6, 2026, 16:43 ET. No prices; not investment advice.